EcoDrugPlus

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSOTSG00005011158
Gene Symbol: LOC112262764
2 Cross references
204 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSOTSG00005034503
Gene Symbol: LOC112262764
2 Cross references
204 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSOTSG00005023812
Gene Symbol: LOC112229828
3 Cross references
180 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSOTSG00005045343
Gene Symbol: LOC112229828
3 Cross references
180 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSOTSG00005044041
Gene Symbol: LOC112253937
3 Cross references
170 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor 1

Ensembl ID : ENSOTSG00005041362
Gene Symbol: GNRHR1
1 Cross references
129 Possible Orthologues:

Gonadotropin Releasing Hormone Receptor 1

Ensembl ID : ENSOTSG00005009671
Gene Symbol: GNRHR1
1 Cross references
129 Possible Orthologues:

Granzyme H

Ensembl ID : ENSOTSG00005037798
Gene Symbol: GZMH
3 Cross references
990 Possible Orthologues:

Growth Hormone Secretagogue Receptor A

Ensembl ID : ENSOTSG00005015875
Gene Symbol: GHSRA
1 Cross references
208 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSOTSG00005018356
Gene Symbol: GUCY1A1
3 Cross references
195 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSOTSG00005005428
Gene Symbol: GUCY1A2
1 Cross references
197 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSOTSG00005036506
Gene Symbol: GUCY1A2
1 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).